Nanjing Vishee Medical Technology Co Ltd
SSE:688580

Watchlist Manager
Nanjing Vishee Medical Technology Co Ltd Logo
Nanjing Vishee Medical Technology Co Ltd
SSE:688580
Watchlist
Price: 30.3 CNY 0.26% Market Closed
Market Cap: 2.9B CNY
Have any thoughts about
Nanjing Vishee Medical Technology Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

18.8
Current
23.5
Median
12.7
Industry
Lower than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
18.8
=
Enterprise Value
1.9B CNY
/
EBITDA
99.6m CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
12.1
2-Years Forward
EV/EBITDA
9.5
3-Years Forward
EV/EBITDA
7.8

See Also

Discover More